Browse > Article
http://dx.doi.org/10.4162/nrp.2018.12.2.110

Ethanol extract of Allium fistulosum inhibits development of non-alcoholic fatty liver disease  

Hwang, Jin-Taek (Korea Food Research Institute)
Shin, Eun Ju (Korea Food Research Institute)
Chung, Min-Yu (Korea Food Research Institute)
Park, Jae Ho (Korea Food Research Institute)
Chung, Sangwon (Korea Food Research Institute)
Choi, Hyo-Kyoung (Korea Food Research Institute)
Publication Information
Nutrition Research and Practice / v.12, no.2, 2018 , pp. 110-117 More about this Journal
Abstract
BACKGROUND/OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and is closely associated with metabolic syndrome. In the present study, we observed the effect of ethanol extract of Allium fistulosum (EAF) on NAFLD and have suggested the possibility of using EAF as a natural product for application in the development of a treatment for NAFLD. MATERIALS/METHODS: The preventive effect on hepatic lipid accumulation was estimated by using an oleic acid (OA)-induced NAFLD model in vitro and a Western diet (high-fat high-sucrose; WD)-induced obese mouse model. Animals were divided into three groups (n = 7): normal diet group (ND), WD group, and WD plus 1% EAF group. RESULTS: EAF reduced OA-stimulated lipid accumulation in HepG2 cells in the absence of cellular cytotoxicity and significantly blocked transcriptional activation of sterol regulatory element-binding protein 1 and fatty acid synthase genes. Subsequently, we investigated these effects in vivo in mice fed either ND or WD in the presence or absence of EAF supplementation. In comparison to the ND controls, the WD-fed mice exhibited increases in body weight, liver weight, epididymal fat weight, and accumulation of fat in hepatocytes, and these effects were significantly attenuated by EAF supplementation. CONCLUSIONS: Allium fistulosum attenuates the development of NAFLD, and EAF elicits anti-lipogenic activity in liver. Therefore, EAF represents a promising candidate for use in the development of novel therapeutic drugs or drug combinations for the prevention and treatment of NAFLD.
Keywords
Non-alcoholic fatty liver disease (NAFLD); metabolic syndrome; western diet; lipogenesis; HepG2 cells;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21.   DOI
2 Cohen JC, Hortaon JD, Horbbes HH. Human fatty liver disease: old questions and new insights. Science 2011;332:1519-23.   DOI
3 Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-52.   DOI
4 Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004;10:355-61.   DOI
5 Lei F, Zhang ZN, Wang W, Xing DM, Xie WD, Su N, Du LJ. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced ovese mice. Int J Obes (Lond) 2007;31:1023-9.   DOI
6 Kang OH, Kin SB, Seo YS, Joung DK, Mun SH, Choi JG, Lee YM, Kang DG, Lee HS, Kwon DY. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells. Eur Rev Med Pharmacol Sci 2013;17:2578-86.
7 Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109:1125-31.   DOI
8 Horton JD, Bashmakov Y, Shimomura I, Shimano H. Regulation o sterol regylatiory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A 1998;95:5987-92.   DOI
9 Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 2003;100:12027-32.   DOI
10 Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997;99:838-45.   DOI
11 Aoyama S, Hiraike T, Yamamoto Y. Antioxidant, lipid-lowering and antihypertensive effects of red welsh onion (Allium fistulosum) in spontaneously hypertensive rats. Food Sci Technol Res 2008;14:99-103.
12 Wang BS, Chen JH, Liang YC, Duh PD. Effects of welsh onion on oxidation of low-density lipoprotein and nitric oxide production in macrophage cell line RAW 264.7. Food Chem 2005;91:147-55.   DOI
13 Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007;15:252-9.   DOI
14 Sala A, Folco G. Actual role of prostaglandins in inflammation. Drug Investig 1991;3:4-9.   DOI
15 Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 2013;218:R25-36.   DOI
16 Tilg H, Moschen AR. Evolution on inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010;52:1836-46.   DOI
17 Lima-Cabello E, Garcia-Mediavilla MV, Miguilena-Colina ME, Vargas-Castrillon J, Lozano-Rodriguez T, Femandez-Bermejo M, Olcoz JL, Conzalez-Gallego J, Garcia-Monzon C, Sanchez-Campos S. Enhanced expression on pro-inflammatory mediators and liver X-receptorregulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin Sci 2011;120:239-50.   DOI
18 Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 2011;458:511-23.
19 Watanabe T, Hata K, Hiwatashi K, Hori K, Suzuki N, Itoh H. Suppression of murine peradipocyte differentiation and reduction of visceral fat accumulation by a Petasites Japonicus ethanol extract in mice fed a high-fat diet. Biosci Biotechnol Biochem 2010;74:499-503.   DOI
20 Willebrords J, Pereira I, Maes M, Yanguas S, Colle I, Bossche B, Silva T, Oliveira C, Andraus W, Alves V, Cogliati B, Vinken M. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res 2015;59:106-25.   DOI
21 Bordia A, Verma SK, Vyas AE, Khabya BL, Rathore AS, Bhu N, Dedi HK. Effect of essential oil and garlic on experimental atherosclerosis in rabbits. Atherosclerosis 1977;26:379-86.   DOI
22 Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistrere WF, Woods SC, Seeley RJ. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010;52:934-44.   DOI
23 Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008;295:G987-95.   DOI
24 Machado MV, Michelotti GA, Xie G, Almeida Pereira T, Boursier J, Bohnic B, Guy CD, Diehl AM. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS One 2015;10:e0127991.
25 Almind K, Kahn CR. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 2004;53:3274-85.   DOI
26 Hoevenaars EP, Keijer J, Swarts HJ, Snaas-Alders S, Bekkenkamp-Grovenstein M, van Schothorst EM. Effects of dietary history on energy metabolism and physiological parameters in C57BL/6J mice. Exp Physiol 2013;98:1053-62.
27 Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1998;58:257-63.   DOI
28 Thomson M, Al-Qattan KK, Bordia T, Ali M. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J Nutr 2006;136:800S-802S.   DOI
29 Tolman KG, Dalpiaz AS. Treatment of non-alcoholic fatty liver disease. Ther Clin Risk Manag 2007;3:1153-63.
30 Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998;15:246-58.
31 Chalasani N, Guo X, Loomba R, Goodarzi MO, Haritunians T, Kwon S, Cui J, Taylor KD, Wilson L, Cummings OW, Chen YD, Rotter JI; Nonalcoholic Steatohepatitis Clinical Research Network. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 2010;139:1567-76, 1576.e1-6.
32 Anstee QM, Day CP. The genetics NAFLD. Nat Rev Gastroenterol Hepatol 2013;10:645-55.   DOI
33 Ferre P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010;12 Suppl 2:83-92.   DOI
34 Yamamoto Y, Aoyama S, Hamaguchi N, Rhi GS. Antioxidative and antihypertensive effects of Welsh onion on rats fed with a high-fat high-sucrose diet. Biosci Biotechnol Biochem 2005;69:1311-7.
35 Sung YY, Yoon Y, Kim SJ, Yang WK, Kim HK. Anti-obesity activity of Allium fistulosum L. extract by downregulation of the expression of lipogenic genes in high-fat diet-induced obese mice. Mol Med Rep 2011;4:431-5.
36 Fenwick GR, Hanley AB. The genius Allium-part 1. Crit Rev Food Sci Nutr 1985;22:199-271.   DOI
37 Chen JH, Chen HI, Wang JS, Tsai SJ, Jen CJ. Effects of Welsh onion extracts on human platelet function in vitro. Life Sci 2000;66:1571-9.   DOI
38 Yamamoto Y, Yasuoka A. Welsh onion attenuates hyperlipidemia in rats fed on high-fat high-sucrose diet. Biosci Biotechnol Biochem 2010;74:402-4.   DOI
39 Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S. MeComico A, Masuoko H, Gores G. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 2011;301:G825-34.
40 Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7:27-31.   DOI
41 Wang BS, Huang GJ, Lu YH, Chang LW. Anti-inflammatory effects of an aqueous extract of Welsh onion green leaves in mice. Food Chem 2013;138:751-6.
42 Zhu C, Xie P, Zhao F, Zhang L, An W, Zhan Y. Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol. Int J Clin Exp Pathol 2014;7:6807-13.
43 Beuchat LR. Control of foodborne pathogens and spoilage microorganisms by naturally occurring antimicrobials. In: Wilson CL, Droby S, editors. Microbial Food Contamination. Boca Raton (FL): CRC Press; 2001. p.149-70.
44 Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic. Hepatology 2002;35:367-72.   DOI
45 Cui W, Chen SL, Hu KQ. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res 2010;2:95-104.